Previous studies have found lower mortality and renal failure in patients with SBP given IV albumin, but it is unclear if all patients benefit. This retrospective analysis found no benefit of albumin in those at low risk (bun<11 and bilirubin <~4 mg/dL), but did find a benefit in those at high risk (bun>11 or bilirubin >~4 mg/dL). Albumin should not be given to SBP patients with normal BUN and bilirubin (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.